Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Drugs and Chemicals›Cellobiose
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Cellobiose

Drugs and Chemicals · NLM MeSH · updated 2026-10-31 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 5 min read

A disaccharide consisting of two glucose units in beta (1-4) glycosidic linkage.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (889 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

A disaccharide consisting of two glucose units in beta (1-4) glycosidic linkage. Obtained from the partial hydrolysis of cellulose.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: 4-O-beta-D-Glucopyranosyl-D-glucopyranose; 4 O beta D Glucopyranosyl D glucopyranose.

Where it fits in the MeSH classification

Broader topics
Cellulose; Disaccharides

Research landscape

PubMed indexes 1,535 records tagged with the MeSH heading “Cellobiose” (counts retrieved 2026-10-31). 256 of them (16.7%) were published from 2020 onward, and the busiest period so far is 2010-2019 with 570 records.

Reviews account for 17 records (1.1%) and meta-analyses for 0. Randomized controlled trials number 1 (0.1%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 387 records; 2000-2009: 322 records; 2010-2019: 570 records; 2020 onward: 256 records387through 19993222000-20095702010-20192562020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 1999387
2000-2009322
2010-2019570
2020 onward256
Share of records by publication typeReviews: 1.1 percent; Meta-analyses: 0.0 percent; Randomized controlled trials: 0.1 percentReviews1.1% (17)Meta-analyses0.0% (0)Randomized controlled trials0.1% (1)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 1,535 PubMed records
TypeRecordsShare
Reviews171.1%
Meta-analyses00.0%
Randomized controlled trials10.1%

Method: PubMed query "Cellobiose"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-31.

Reading the evidence in drugs and chemicals

Studies of a chemical or drug can answer very different questions: what it is and how it behaves in cells and animals, how the body handles it, and whether it changes outcomes in people. Laboratory and animal findings often do not carry over to patients, and observational studies of exposures are confounded by who uses a substance and why. Nothing on this page is a recommendation to use, avoid, start or stop any substance or medicine; talk to a qualified clinician or pharmacist about your own situation. Check the dose, the species, the comparison group and whether a patient-relevant outcome was measured.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Functional metagenomics reveals abundant polysaccharide-degrading gene clusters and cellobiose utilization pathways within gut microbiota of a wood-feeding higher termite
Liu N, Li H, Chevrette MG, Zhang L, Cao L, Zhou H, et al.
2019Research article
Design not recorded in structured metadata
90cc by
PMID 30116044 · DOI · PMC6298952
Directed evolution of a cellobiose utilization pathway in Saccharomyces cerevisiae by simultaneously engineering multiple proteins
Eriksen DT, Hsieh PC, Lynn P, Zhao H
2013Research article
Design not recorded in structured metadata
43cc by
PMID 23802545 · DOI · PMC3702475
Biochemical properties of GH94 cellodextrin phosphorylase THA_1941 from a thermophilic eubacterium Thermosipho africanus TCF52B with cellobiose phosphorylase activity
Wu Y, Mao G, Fan H, Song A, Zhang YP, Chen H
2017Research article
Design not recorded in structured metadata
27cc by
PMID 28687766 · DOI · PMC5501786
Characterization of novel cellobiose 2-epimerases from Teredinibacter Haidensis and Cellvibrio Japonicus
Liu Y, Lutz-Wahl S, Fischer L
2026Research article
Design not recorded in structured metadata
0cc by
PMID 42316138 · DOI · PMC13281645

Functional metagenomics reveals abundant polysaccharide-degrading gene clusters and cellobiose utilization pathways within gut microbiota of a wood-feeding higher termite [1]

Research article Liu N, Li H, Chevrette MG, Zhang L, Cao L, Zhou H, et al. · · 2019 · cited 90 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Plant cell-wall polysaccharides constitute the most abundant but recalcitrant organic carbon source in nature.
Closing excerpt
Collectively, these results provide an in-depth view of the adaptation and digestive strategies employed by gut microbiota within this tiny-yet-efficient host-associated ecosystem.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (233 words)

Plant cell-wall polysaccharides constitute the most abundant but recalcitrant organic carbon source in nature. Microbes residing in the digestive tract of herbivorous bilaterians are particularly efficient at depolymerizing polysaccharides into fermentable sugars and play a significant support role towards their host's lifestyle. Here, we combine large-scale functional screening of fosmid libraries, shotgun sequencing, and biochemical assays to interrogate the gut microbiota of the wood-feeding "higher" termite Globitermes brachycerastes. A number of putative polysaccharide utilization gene clusters were identified with multiple fibrolytic genes. Our large-scale functional screening of 50,000 fosmid clones resulted in 464 clones demonstrating plant polysaccharide-degrading activities, including 267 endoglucanase-, 24 exoglucanase-, 72 β-glucosidase-, and 101 endoxylanase-positive clones. We sequenced 173 functionally active clones and identified ~219 genes encoding putative carbohydrate-active enzymes (CAZymes) targeting cellulose, hemicellulose and pectin. Further analyses revealed that 68 of 154 contigs encode one or more CAZyme, which includes 35 examples of putative saccharolytic operons, suggesting that clustering of CAZymes is common in termite gut microbial inhabitants. Biochemical characterization of a representative xylanase cluster demonstrated that constituent enzymes exhibited complementary physicochemical properties and saccharolytic capabilities. Furthermore, diverse cellobiose-metabolizing enzymes include β-glucosidases, cellobiose phosphorylases, and phopho-6-β-glucosidases were identified and functionally verified, indicating that the termite gut micro-ecosystem utilizes diverse metabolic pathways to interconnect hydrolysis and central metabolism. Collectively, these results provide an in-depth view of the adaptation and digestive strategies employed by gut microbiota within this tiny-yet-efficient host-associated ecosystem.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 30116044 · DOI · PMC6298952

Directed evolution of a cellobiose utilization pathway in Saccharomyces cerevisiae by simultaneously engineering multiple proteins [2]

Research article Eriksen DT, Hsieh PC, Lynn P, Zhao H · · 2013 · cited 43 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundThe optimization of metabolic pathways is critical for efficient and economical production of biofuels and specialty chemicals.
Closing excerpt
The improved in vivo cellobiose utilization demonstrated here could help to decrease the in vitro enzyme load in biomass pretreatment, ultimately contributing to a reduction in the high cost of biofuel production.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (195 words)

BackgroundThe optimization of metabolic pathways is critical for efficient and economical production of biofuels and specialty chemicals. One such significant pathway is the cellobiose utilization pathway, identified as a promising route in biomass utilization. Here we describe the optimization of cellobiose consumption and ethanol productivity by simultaneously engineering both proteins of the pathway, the β-glucosidase (gh1-1) and the cellodextrin transporter (cdt-1), in an example of pathway engineering through directed evolution.ResultsThe improved pathway was assessed based on the strain specific growth rate on cellobiose, with the final mutant exhibiting a 47% increase over the wild-type pathway. Metabolite analysis of the engineered pathway identified a 49% increase in cellobiose consumption (1.78 to 2.65 g cellobiose/(L · h)) and a 64% increase in ethanol productivity (0.611 to 1.00 g ethanol/(L · h)).ConclusionsBy simultaneously engineering multiple proteins in the pathway, cellobiose utilization in S. cerevisiae was improved. This optimization can be generally applied to other metabolic pathways, provided a selection/screening method is available for the desired phenotype. The improved in vivo cellobiose utilization demonstrated here could help to decrease the in vitro enzyme load in biomass pretreatment, ultimately contributing to a reduction in the high cost of biofuel production.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 23802545 · DOI · PMC3702475

Biochemical properties of GH94 cellodextrin phosphorylase THA_1941 from a thermophilic eubacterium Thermosipho africanus TCF52B with cellobiose phosphorylase activity [3]

Research article Wu Y, Mao G, Fan H, Song A, Zhang YP, Chen H · · 2017 · cited 27 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
A hypothetic gene (THA_1941) encoding a putative cellobiose phosphorylase (CBP) from Thermosipho africanus TCF52B has very low amino acid identities (less than 12%) to all known GH94 enzymes.
Closing excerpt
africanus TCF52B was also discussed.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (193 words)

A hypothetic gene (THA_1941) encoding a putative cellobiose phosphorylase (CBP) from Thermosipho africanus TCF52B has very low amino acid identities (less than 12%) to all known GH94 enzymes. This gene was cloned and over-expressed in Escherichia coli BL21(DE3). The recombinant protein was hypothesized to be a CBP enzyme and it showed an optimum temperature of 75 °C and an optimum pH of 7.5. Beyond its CBP activity, this enzyme can use cellobiose and long-chain cellodextrins with a degree of polymerization of greater than two as a glucose acceptor, releasing phosphate from glucose 1-phosphate. The catalytic efficiencies (k cat/K m) indicated that cellotetraose and cellopentaose were the best substrates for the phosphorolytic and reverse synthetic reactions, respectively. These results suggested that this enzyme was the first enzyme having both cellodextrin and cellobiose phosphorylases activities. Because it preferred cellobiose and cellodextrins to glucose in the synthetic direction, it was categorized as a cellodextrin phosphorylase (CDP). Due to its unique ability of the reverse synthetic reaction, this enzyme could be a potential catalyst for the synthesis of various oligosaccharides. The speculative function of this CDP in the carbohydrate metabolism of T. africanus TCF52B was also discussed.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 28687766 · DOI · PMC5501786

Characterization of novel cellobiose 2-epimerases from Teredinibacter Haidensis and Cellvibrio Japonicus [4]

Research article Liu Y, Lutz-Wahl S, Fischer L · · 2026

Abstract reading summary — source excerpts
Opening excerpt
BackgroundCellobiose 2-epimerases (CEs) are promising enzymes that catalyze the conversion of lactose to the bioactive disaccharides epilactose and lactulose.
Closing excerpt
ConclusionsThis study identified two new CEs that exhibit interesting catalytic properties for possible application in the generation of disaccharides with prebiotic properties from lactose at low temperatures.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (268 words)

BackgroundCellobiose 2-epimerases (CEs) are promising enzymes that catalyze the conversion of lactose to the bioactive disaccharides epilactose and lactulose. Low-temperature (≤8 °C) lactose bioconversion is essential in dairy applications to prevent microbial contamination. Unfortunately, most CEs are not particularly active at these low temperatures. Therefore, this work aims to discover and characterize novel cold-active CEs.ResultsTwo novel mesophilic CEs from Teredinibacter haidensis (ThCE) and Cellvibrio japonicus (CjCE) were characterized, which showed both epi- and isomerization activity additionally at low temperatures. ThCE showed a maximum epimerization activity (595.4 ± 4.4 nkat/mg protein) at pH 7.5 and 35 °C, while CjCE achieved maximum epimerization activity (887.4 ± 3.9 nkat/mg protein) at pH 9.5 and 40 °C. In addition, CjCE maintained an >80% activity across a wide pH (6-9.5) and temperature range (30-45 °C). Both CEs exhibited significant activity and stability at 8 °C. Specifically, ThCE and CjCE retained around 20 and 40% of their epimerization activity at 8 °C and showed half-lives of 96.3 and 72.2 days, respectively. Moreover, CjCE was also found to be capable of catalyzing the isomerization reaction at 8 °C. The isomerization activity of ThCE and CjCE increased ~370-fold (70.8 ± 2.7 nkat/mg protein) and ~230-fold (66.1 ± 0.3 nkat/mg protein), respectively, at lactose concentrations up to 600 mM (35 °C for ThCE and 40 °C for CjCE). This demonstrates how important it is to conduct investigations of CEs for lactose isomerization to lactulose up to the solubility limit of lactose.ConclusionsThis study identified two new CEs that exhibit interesting catalytic properties for possible application in the generation of disaccharides with prebiotic properties from lactose at low temperatures.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42316138 · DOI · PMC13281645

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Reactor design for minimizing product inhibition during enzymatic lignocellulose hydrolysis: I. Significance and mechanism of cellobiose and glucose inhibition on cellulolytic enzymes [5]
    Andrić P, Meyer AS, Jensen PA, Dam-Johansen K · Biotechnol Adv · 2010 · cited 118 times (Europe PMC)
  • Research article Intracellular cellobiose metabolism and its applications in lignocellulose-based biorefineries [6]
    Parisutham V, Chandran SP, Mukhopadhyay A, Lee SK, Keasling JD · Bioresour Technol · 2017 · cited 53 times (Europe PMC)
  • Research article The cellobiose permease of Escherichia coli consists of three proteins and is homologous to the lactose permease of Staphylococcus aureus [7]
    Reizer J, Reizer A, Saier MH · Res Microbiol · 1990 · cited 35 times (Europe PMC)
  • Research article Phosphorylase-catalyzed bottom-up synthesis of short-chain soluble cello-oligosaccharides and property-tunable cellulosic materials [8]
    Nidetzky B, Zhong C · Biotechnol Adv · 2021 · cited 32 times (Europe PMC)
  • Research article Advances and prospects on production of lactulose and epilactose by cellobiose 2-epimerases: A review [9]
    Pang B, Yang J, Song M, Zhang W, Qian S, Xu M, et al. · Int J Biol Macromol · 2025 · cited 9 times (Europe PMC)
  • Research article Cellobiose lipids: applications, production, and downstream processing [10]
    Valkenburg AD, Ncube MZ, Teke GM, van Rensburg E, Pott RWM · Trends Biotechnol · 2025 · cited 1 times (Europe PMC)

References

  1. Liu N, Li H, Chevrette MG, Zhang L, Cao L, Zhou H, et al.. Functional metagenomics reveals abundant polysaccharide-degrading gene clusters and cellobiose utilization pathways within gut microbiota of a wood-feeding higher termite. . 2019. PMID 30116044 · DOI · PMC6298952
  2. Eriksen DT, Hsieh PC, Lynn P, Zhao H. Directed evolution of a cellobiose utilization pathway in Saccharomyces cerevisiae by simultaneously engineering multiple proteins. . 2013. PMID 23802545 · DOI · PMC3702475
  3. Wu Y, Mao G, Fan H, Song A, Zhang YP, Chen H. Biochemical properties of GH94 cellodextrin phosphorylase THA_1941 from a thermophilic eubacterium Thermosipho africanus TCF52B with cellobiose phosphorylase activity. . 2017. PMID 28687766 · DOI · PMC5501786
  4. Liu Y, Lutz-Wahl S, Fischer L. Characterization of novel cellobiose 2-epimerases from Teredinibacter Haidensis and Cellvibrio Japonicus. . 2026. PMID 42316138 · DOI · PMC13281645
  5. Andrić P, Meyer AS, Jensen PA, Dam-Johansen K. Reactor design for minimizing product inhibition during enzymatic lignocellulose hydrolysis: I. Significance and mechanism of cellobiose and glucose inhibition on cellulolytic enzymes. Biotechnol Adv. 2010. PMID 20080173 · DOI
  6. Parisutham V, Chandran SP, Mukhopadhyay A, Lee SK, Keasling JD. Intracellular cellobiose metabolism and its applications in lignocellulose-based biorefineries. Bioresour Technol. 2017. PMID 28535986 · DOI
  7. Reizer J, Reizer A, Saier MH. The cellobiose permease of Escherichia coli consists of three proteins and is homologous to the lactose permease of Staphylococcus aureus. Res Microbiol. 1990. PMID 2092358 · DOI
  8. Nidetzky B, Zhong C. Phosphorylase-catalyzed bottom-up synthesis of short-chain soluble cello-oligosaccharides and property-tunable cellulosic materials. Biotechnol Adv. 2021. PMID 32966861 · DOI
  9. Pang B, Yang J, Song M, Zhang W, Qian S, Xu M, et al.. Advances and prospects on production of lactulose and epilactose by cellobiose 2-epimerases: A review. Int J Biol Macromol. 2025. PMID 39984086 · DOI
  10. Valkenburg AD, Ncube MZ, Teke GM, van Rensburg E, Pott RWM. Cellobiose lipids: applications, production, and downstream processing. Trends Biotechnol. 2025. PMID 39490222 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-31.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • MaltoseDrugs and Chemicals
  • CelluloseDrugs and Chemicals
  • CyclodextrinsDrugs and Chemicals
  • Dextran SulfateDrugs and Chemicals
  • DextransDrugs and Chemicals
  • GlucansDrugs and Chemicals

All 546 articles in Drugs and Chemicals →

At a glance

1,535
PubMed records on this heading
17%
published since 2020
17
review articles
1
randomized trials
10
verified references below

Counts come from PubMed on 2026-10-31; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • MaltoseDrugs and Chemicals
  • CelluloseDrugs and Chemicals
  • CyclodextrinsDrugs and Chemicals
  • Dextran SulfateDrugs and Chemicals
  • DextransDrugs and Chemicals

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support